Bigul

UK pitches new industry plan as Brexit looms, wins Merck, Qiagen's support

The government said it had secured major investments from global healthcare companies ahead of the publication of the strategy
27-11-2017
Bigul

Outcome of Board Meeting

With reference to the above captioned subject, we are enclosing herewith a copy of un-audited Financial Results along with the Limited Review Report for the period ended September 30, 2017 as approved by the Board of Directors of the Company at its meeting held on November 14, 2017.The Board Meeting commenced at 03.45 p.m. and concluded at 04.45 p.m. The Un-audited Financial Results will be published in the newspapers within the stipulated time as per the SEBI Listing Regulations.
14-11-2017
Bigul

Outcome of Board Meeting

With reference to the above captioned subject, we are enclosing herewith a copy of un-audited Financial Results along with the Limited Review Report for the period ended September 30, 2017 as approved by the Board of Directors of the Company at its meeting held on November 14, 2017.The Board Meeting commenced at 03.45 p.m. and concluded at 04.45 p.m. The Un-audited Financial Results will be published in the newspapers within the stipulated time as per the SEBI Listing Regulations.
14-11-2017
Bigul

Board Meeting On Tuesday, November 14, 2017

In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 interalia, to consider and approve the un-audited financial results for the quarter ended September 30, 2017.
26-10-2017
Bigul

Statement Of Investor Grievance Report For The Quarter Ended September 2017.

With reference to the above we are enclosing herewith quarterly investor grievance report as per Reg. 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended September 30, 2017. Kindly acknowledge receipt.
12-10-2017
Bigul

Pfizer may sell or spin off its $15-billion consumer healthcare business

Germany's Merck KGaA is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion
11-10-2017
Bigul

Updates

Announcement for Closure of trading window. This is for the information of all concerned that the Company has issued the notice on September 13, 2017 to close its trading window due to third quarter results for the quarter ending September 30, 2017. Please note that the Company vide earlier notification dated September 05, 2017 to its employees had closed trading window due to Merck KGaA, the ultimate holding company of the Company had announced...
22-09-2017
Bigul

Merck may sell consumer health business to focus on new drugs

is exploring sale or strategic partnership for its consumer health business including India as it continues focus to develop innovative drugs.The plan to hive off consumer health business is second such move by the drug maker which sold its biosimilar business to Fresenius earlier this year.The German drug maker Merck KGaA operates in 66 countries and its business is spread across pharmaceuticals, laboratory solutions, chemicals and liquid crystals. In 2016 the company had global sales of over 15 billion Euros. Consumer health contributed to 850 million Euros.Merck, which has been present in India for over five decades, operates through five main companies including its listed entity Merck Limited. Merck did not respond to an email query and did not share the most recent consumer health sales figures for India. Merck Ltd 2015 annual report shows the business contributed over Rs 200 crore or around 24 per cent of its Rs 904 crore sales (the company follows January-December...
07-09-2017
Bigul

Press Release / Media Release

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is for the information of all concerned that Merck KGaA, Germany, the ultimate holding Company of the Company has announced that it is preparing for strategic options for its Consumer health business globally including a potential full or partial sale of the business as well as strategic partnerships. This strategic initiative...
05-09-2017
Bigul

Merck CEO Kenneth Frazier resigns from Trump council over Charlottesville

(Reuters) - Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
15-08-2017
Next Page
Close

Let's Open Free Demat Account